Navigation Links
Survey Reveals Roughly 3 in 5 Women May be Mistreating Their Yeast Infections
Date:9/9/2010

SKILLMAN, N.J., Sept. 9 /PRNewswire/ -- For more information, please go to: http://monistat.presslift.com/yeastinfections.

Few women go through life having never suffered from the uncomfortable symptoms of a yeast infection.  In fact, nearly 3 in 4 (72 percent) women will experience their first yeast infection before age 25. (1)  Furthermore, the incidence of yeast infections is highest among young women ages 18-24 (2), who are new to the category and uncertain about symptoms and available treatment options.  According to a recent survey of women ages 18-24 commissioned by the MONISTAT® Brand, sixty-one percent (61 percent) of young women are unsure about which, if any, over the-counter products can cure a yeast infection.

"Many women don't realize that once they've identified they have a yeast infection they can easily treat it on their own terms," said Dr. Suzanne Gilberg-Lenz, a board-certified OB/GYN who practices in Beverly Hills, California.  Dr. Lenz, a partner in the MONISTAT® survey, reviewed the full results and offers the following advice to help cure the confusion around yeast infections:

Cure vs. Care

  • More than 1/3 (37 percent) of women incorrectly believe that treating the symptoms of a yeast infection is the same as curing the infection.

"I see many women who have unsuccessfully tried to treat their yeast infections," said Dr. Lenz.  "One of the biggest mistakes I see my patients make is using external symptom relief creams, such as Vagisil® (3) to treat a yeast infection.  Vagisil®(4) does not cure the infection; it only temporarily masks or relieves symptoms."

Over-the-Counter Cure

  • Thirty-eight percent (38 percent) of women mistakenly beli
    '/>"/>

SOURCE The MONISTAT(R) Brand
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. For Treatment of Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia, 41 Percent of Surveyed European Hematologist-Oncologists Say MabTheras Favorable Efficacy Profile is the Most Significant Driver of Their Use of This Agent
2. In First- and Second-Line Treatment of Clostridium Difficile Infection, Nearly 70 Percent of Surveyed Infectious Disease Specialists and Internists Will Use Fidaxomicin and Nearly Half Will Use CDA1/CDB1
3. Hot Times in the City: As Summer Temperatures Soar, Pulse of Passion Survey Reveals What Makes Americans Sizzle in Relationships
4. Usability Sciences Corporation Launches WebIQ Pharma - An Intelligent Survey Tool That Allows Pharma Sites to Measure and Improve Website Effectiveness
5. An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists
6. Reportlinker Adds U.S. Market for Hearing Aids and Audiology Devices 2010 (Includes Audiologist Survey)
7. Frost & Sullivan Recognizes Timoptic(R) (timolol maleate) as Best Brand Name Beta Blocker for Glaucoma: Timoptic Brand is Highest Rated in Survey of Ophthalmologists
8. Partnership for a Drug-Free Americas 21st Annual Teen Survey Shows No Significant Increase in Over-the-Counter Medicine Abuse Rates
9. New Survey Shows Seniors Struggle Under the Weight of Multiple Medication Use
10. Boston Scientific Announces Settlement of DOJ Investigation Relating to Post-Market Surveys Conducted By Guidant
11. Cimzia Draws Even With Simponi at Six Months Post Launch According to Recent BioTrends Survey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... N.C. , March 31, 2015 PGI ... capabilities in North America at ... facility. The anticipated plant expansion is centered ... a need for differentiated products for personal care product ... state-of-the-art printing capabilities with in-line slitting and packaging, will ...
(Date:3/31/2015)... Immune Pharmaceuticals Inc. ("Immune", the "Company") (NASDAQ: ... expand its planned bullous pemphigoid (BP) clinical development for ... Pemphigoid is an orphan auto-immune blistering disease of the ... Europe . As previously ... Phase II clinical trial in Israel ...
(Date:3/31/2015)... March 31, 2015   Unique Pharmaceuticals , a ... complete and the company has initiated sterile compounding operations ... goal as a company is to meet and exceed ... . "Meeting the new regulations is validation of our ... the future of our industry, investing in its continued ...
Breaking Medicine Technology:PGI Expands Manufacturing Capabilities At Mexico Plant 2Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 2Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 3Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 4Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 2Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 3
... certain kidney transplant recipients off,anti-rejection drugs following surgery, ... surgery,anti-rejection drugs for the organ recipient are a ... effects, including infections, heart disease and,cancer. A team ... Northwestern,University,s Feinberg School of Medicine, is working with ...
... Following FDA Approval, Company Announces $7,800 Wholesale Price for ... ... AIDS Healthcare,Foundation (AHF) today urged Tibotec Pharmaceuticals Ltd., a division of,Johnson ... newest,AIDS drug, etravirine (TMC 125), a non-nucleoside reverse transcriptase,inhibitor, (NNRTI), which ...
Cached Medicine Technology:Northwestern Memorial Transplant Program Initiates New Study 2Northwestern Memorial Transplant Program Initiates New Study 3Northwestern Memorial Transplant Program Initiates New Study 4AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine 2AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine 3
(Date:3/31/2015)... 31, 2015 Horizon Blue Cross Blue ... its efforts to combat health insurance fraud resulted in ... of monies recovered and losses avoided -- in 2014. ... Horizon BCBSNJ created its fraud fighting, Special Investigations Unit ... efforts have saved members $261 million. , “Our ...
(Date:3/31/2015)... Altima Technologies, Inc., the maker ... documenting and diagramming data center assets and audio-video ... Manufacturer / Device Model, Dell N3000 Series, Dell ... Dell PowerEdge r630, Cisco Catalyst 3850 Series, HP ... 100K, VMAX 200K, VMAX 400K , “With NetZoom ...
(Date:3/31/2015)... The Oliver Law Group, who ... notes that filings for testosterone lawsuits that allege ... complications associated with testosterone therapy products such as ... steady pace. The website for the U.S. District ... lawsuits have been centralized, shows 1,291 testosterone lawsuits ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 When SIGVARIS launched ... company’s most successful product launch to date. Women immediately fell ... is giving women another reason to love EVERSHEER with the ... for spring. , Lavender mist pairs perfectly with a ... neutral outfits. For women looking to add a hint of ...
(Date:3/31/2015)... 2015 India Network Foundation , ... a travel advisory to all USA bound international travelers ... United States are higher than many other countries and ... For example, a coronary artery bypass graft costs ... about $34,358 . Visitors are advised to get ...
Breaking Medicine News(10 mins):Health News:Horizon Blue Cross Blue Shield of New Jersey Saves Members, Health System a Record $45.4 Million through Anti-fraud Efforts 2Health News:Altima Adds More Hardware Devices to its NetZoom™ Visio® Stencils Device Library 2Health News:Testosterone Lawsuit Filings Rise To Over 1,200 In Multidistrict Litigation Pending In Northern Illinois Federal Court Reports The Oliver Law Group 2Health News:Testosterone Lawsuit Filings Rise To Over 1,200 In Multidistrict Litigation Pending In Northern Illinois Federal Court Reports The Oliver Law Group 3Health News:Put Spring in Your Step with SIGVARIS’ Top Selling Sheer Hosiery Compression Therapy Brand 2Health News:India Network Foundation issues travel advisory to all US bound travelers on visitor health insurance requirements 2Health News:India Network Foundation issues travel advisory to all US bound travelers on visitor health insurance requirements 3
... February 16, 2011 An article published in a forthcoming ... of the first to provide evidence of the effectiveness ... suffering from posttraumatic stress disorder (PTSD). The study shows ... in PTSD symptoms after an average of seven treatment ...
... Sciences, National Academy of Engineering, Institute of Medicine, and National ... annual meeting of the American Association for the Advancement of ... Washington, D.C. Tribute to Stephen H. ... East (Renaissance Downtown), Stephen Schneider, a renowned climate scientist at ...
... 16, 2011 − One of the tough challenges a parent ... parent the surviving children, and the task begins immediately, according ... moment their child dies, parents are faced with the two ... a child and the ongoing, daily demands from their surviving ...
... HealthDay Reporter , TUESDAY, Feb. 15 (HealthDay News) ... when they,re first tested may not need to be screened ... new study suggests. Dutch researchers presenting the findings ... few men with a PSA below 3.0 ng/ml were likely ...
... newly diagnosed with Alzheimer,s disease or other dementias, and ... how to plan for the patient,s progressive loss of ... by a physician at the San Francisco VA Medical ... "When a patient is diagnosed with Alzheimer,s disease or ...
... -- Psychotherapy triggers changes in the brains of people ... Medication and psychotherapy are used to treat people with ... overwhelming fear of interacting with others and of being ... the neurological effects of psychotherapy (talk therapy) than on ...
Cached Medicine News:Health News:Innovative virtual reality exposure therapy shows promise for returning troops 2Health News:Media advisory -- events at AAAS 2Health News:Media advisory -- events at AAAS 3Health News:Media advisory -- events at AAAS 4Health News:Parenting after the death of a child a difficult balancing act: York U study 2Health News:PSA Test Cut-off Could Signal Low-Risk Prostate Cancer 2Health News:PSA Test Cut-off Could Signal Low-Risk Prostate Cancer 3Health News:Financial planning a key but neglected component of Alzheimer's care, say researchers 2Health News:'Talk Therapy' Can Alter Brain Activity, Research Shows 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: